Standard evidence-based heart failure treatments apply to African Americans, with the specific addition of hydralazine and isosorbide dinitrate recommended to help overcome disparities.
Answers are grounded in this paper and cite their sources.
Supports standard heart failure therapies plus hydralazine-isosorbide dinitrate in African Americans; leaves open prospective validation of disparity reduction.
African Americans are disproportionately affected by heart failure, with a high prevalence at an early age. Hypertension, diabetes, obesity, and chronic kidney disease are all common in African Americans and all predispose to heart failure. Neurohormonal imbalances, endothelial dysfunction, genetic polymorphisms, and socioeconomic factors also contribute. In general, the same evidence-based treatment guidelines that apply to white patients with heart failure also apply to African Americans. However, the combination of hydralazine and isosorbide dinitrate is advised specifically for African Americans.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: